New Orleans Pulmonary Hypertension Biobank

Pulmonary hypertension (PH) is a serious condition characterized by a mean pulmonary artery pressure >=25mmHg on right heart catheterization (RHC). Despite advances in PH care, outcomes are still sub-optimal and further research is required into the pathobiology of the disease and development of biomarkers that can guide clinical care. The investigators are establishing a biobank to collect samples (blood, urine, stool) from patients with pulmonary hypertension, patients at high risk for pulmonary hypertension, healthy controls, and patients undergoing right heart catheterization. Specimens will be stored for future investigations.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Pulmonary Hypertension Cardiovascular Diseases Connective Tissue Diseases Healthy Heart Failure With Normal Ejection Fraction Hypertension Hypertension, Pulmonary Lung Diseases Mixed Connective Tissue Disease Respiratory Tract Diseases Scleroderma, Systemic Skin Diseases Skin and Connective Tissue Diseases Systemic Sclerosis Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University Medical Center-New Orleans

New Orleans, Louisiana, 70112, United States

Location status: Recruiting

Location contact

Matthew Lammi, MD, MSCR

CONTACT

[email protected]

504-568-4634

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Diagnosis of pulmonary hypertension and followed at the Comprehensive Pulmonary Hypertension Center OR
Diagnosis of systemic sclerosis and followed at the Comprehensive Pulmonary Hypertension Center OR
Diagnosis of mixed connective tissue disease and followed at the Comprehensive Pulmonary Hypertension Center OR
Undergoing outpatient right heart catheterization

Exclusion criteria

Age<18
Pregnant
Unable to understand English
Currently incarcerated
Unwilling or unable to sign informed consent

Treatment and study plan

No intervention. Biospecimen collection only

Other

Biospecimen collection

Primary outcomes

Collection of biospecimens

Time frame: 10 years

Biospecimen collection only

Study contacts

Contact information is provided by the study sponsor or research team.

Matthew R Lammi, MD, MSCR

CONTACT

[email protected]

5045684634

Sponsors and collaborators

Lead sponsor

Louisiana State University Health Sciences Center in New Orleans

Other

Registry information

Acronym: NO-PH Biobank

Important dates

Study start: 2017
Primary completion: 2027
Study completion: 2027
First posted: Sep 1, 2017
Registry last updated: Sep 10, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed